Status:
COMPLETED
Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
Lead Sponsor:
Radboud University Medical Center
Conditions:
Pharmacokinetics
Area Under Curve
Eligibility:
All Genders
Up to 18 years
Brief Summary
This is a prospective observational study of MIPD in clinical practice for paediatric kidney transplant patients using tacrolimus and mycophenolic acid in Radboudumc. Dose individualization in paediat...
Eligibility Criteria
Inclusion
- Kidney transplant patients using tacrolimus and/or mycophenolic acid
- Age between 0 and 18 years
- Indication for an AUC measurement - judgement of clinician
Exclusion
- Incapacitated patients
- No informed consent
- Not proficient in the Dutch language
Key Trial Info
Start Date :
March 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 20 2025
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT06095895
Start Date
March 15 2024
End Date
November 20 2025
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6500HB